COST Action CA18218

17th European Public Health Conference

The 17th European Public Health Conference, organised by the European Public Health Association (EUPHA), will take place from 13 to 15 November 2024, with pre-conferences organised on 12 November. The conference will be held at the Lisbon Congress Center, Lisbon, Portugal. Complete information about the congress is available via

During the conference, the European Burden of Disease Network will contribute to a number of workshops on burden of disease assessment. There will also be several abstract and poster presentations on burden of disease by our network members. Below you will find an overview of the different burden of disease sessions planned at the 17th European Public Health Conference.

Burden of disease workshops and skills building seminars

Scientific session: Improving health impact assessment in the context of EU policy cycle
Wed 13/11, 10h30-11h30
Health impacts methodology in the European Commission
— Vitus-Cornelius Van Rij, Belgium
Applying knowledge translation for an effective use of Burden of Disease
— Henk Hilderink, RIVM, Netherlands
Role of epidemiology in the EU policy formulation of chemicals
— Eleonora Chinchio, European Commission
Round table: Towards a research agenda for burden of disease studies
Wed 13/11, 15h15-16h15
Improving transparency: Development of reporting guidelines for burden of disease studies
— Brecht Devleesschauwer, Sciensano, Belgium
Refining current methods: Including comorbidity adjustment in burden of disease estimates
— Michael Porst, RKI, Germany
Working on new applications: Use of economic evaluation in burden of disease estimates
— Michele Cecchini, OECD, France
Working on new topics: Estimation of the burden of zoonotic diseases
— Carlotta di Bari, Sciensano, Belgium
Scientific session: The importance of using country-specific severity distributions in burden of disease indicators
Thu 14/11, 11h45-12h45
Establishing disease models for the Belgian national burden of disease study: challenges and perspectives
— Sarah Nayani, Sciensano, Belgium
Developing survey instruments for low back and neck pain to improve disease severity estimates for burden of disease assessment
— Grant Wyper, PHS, United Kingdom
Exploring changes in the distribution of health status in type 2 diabetes over time - methodological aspects for estimating years lost due to disability for Germany
— Michael Porst, RKI, Germany
Methodological insights into severity distribution of non-fatal cancer burden in Belgium using a microsimulation model (2004-2019)
— Robby De Pauw, Sciensano, Belgium
Skills building seminar: Using health impact assessment for assessing tobacco control policies
Thu 14/11, 15h15-16h15
Calculating potential impact fractions to assess the impact of tobacco control policies
— Ute Mons, University of Cologne, Germany
DYNAMO-HIA: A health impact assessment tool fit for quantifying tobacco control policy
— Stefan Lhachimi, University of Bremen, Germany
Populating HIA of tobacco policies with empirical evidence on behavioral response to price increases
— Ardine De Wit, RIVM, Netherlands
Mind the gap: from real-world policies to health impact assessment modelling
— Sarah Croes, Sciensano, Belgium
Pecha Kucha: Providing BoD estimates on a regional level – necessity in assessing health inequalities
Thu 14/11, 15h15-15h40
Regional inequalities in years of life lost within the European Economic Area: Using the Gini coefficient and slope index of inequality to assess spatial disparities
— Orsolya Varga, University of Debrecen, Hungary
Addressing Regional Health Disparities: Estonia's Approach to Burden of Disease Studies
— Maria Lepnurm, TAI, Estonia
Burden of disease and socioeconomic deprivation in Germany – regional patterns and variations
— Annelene Wengler, RKI, Germany
All-cause Years of life lost due to death at municipality level in Norway. Association to educational attainment and median income
— Carl Baravelli, NIPH, Norway
Scientific session: Confronting the hidden risks: unveiling the disease burden of chemicals in Europe
Fri 15/11, 11h45-12h45
Health consequences of harmful chemicals in foods: insights from the WHO Global Burden of Foodborne Disease Study
— Lea Sletting Jakobsen, DTU, Denmark
Feasibility of using comparative risk assessment for chemical burden of disease assessments
— Dietrich Plass, UBA, Germany
Large scale OECD health valuation study to estimate the economic benefits of chemical regulation
— Irene Hu, OECD, France
Environmental burden of disease related to pyrethroid-insecticide exposure and neurodevelopmental toxicity in Europe based on human biomonitoring
— Anthony Purece, VITO, Belgium
Evolution and future prospects in quantifying the chemical burden in Portugal
— Ricardo Assunção, Egas Moniz, Portugal
Skills building seminar: Methods for measuring the true health cost of pollution
Thu 14/11, 16h45-17h45
Quantifying the health burden of environmental stressors
— Juanita Haagsma, Erasmus MC, Netherlands
Measuring the economic impact of environmental stressors on health
— João Vasco Santos, University of Porto, Portugal
Integrating social inequalities in the burden of environmental stressors
Vanessa Gorasso, Sciensano, Belgium
Scientific session: Economics of Mental Health in the interplay between health systems and public health
Wed 13/11, 10h30-11h30
The economics of mental ill-health in the EU/EEA
Michele Cecchini, OECD, France
Estimating the economic burden of mental and substance use disorders in Belgium
Masja Schmidt, Sciensano, Belgium
Social Inequalities in mental health service use and perceived helpfulness: A global analysis across 111 countries
Christoph Henking, University of Oxford, United Kingdom

Burden of disease abstract presentations

Wednesday 13 November 2024  
9h00-10h00 1.E. - Oral presentations: Understanding the health implications of environmental challenges Burden of disease due to ambient particulate matter pollution in Germany from 2010 to 2021
Dietrich Plass, Germany
9h00-10h00 1.E. - Oral presentations: Understanding the health implications of environmental challenges How ambient NO2 impacts the mortality burden of ischemic heart disease in Portugal (2011-2021)
Marta Clemente, Portugal
9h00-10h00 1.E. - Oral presentations: Understanding the health implications of environmental challenges Health burden and costs attributed to the carbon footprint of health systems in the European Union
Jose Chen-Xu, Portugal
9h00-10h00 1.E. - Oral presentations: Understanding the health implications of environmental challenges How was the impact of heatwaves on daily hospital admissions in Portugal (2000-2018)?
Ana Margarida Alho, Portugal
15h15-16h15 3.P. - Pitch presentations: Data, assessments, impact Using burden of foodborne disease estimates for risk ranking in Denmark
Sara Monteiro Pires, Denmark
16h45-17h45 4.E. - Pitch presentations: Effects of environmental exposure Burden of disease due to road traffic noise in Flanders, Belgium
Arno Pauwels, Belgium
16h45-17h45 4.R. - Poster walk: Public health economics Health & wealth: targeted hygiene reduces the health economic burden of workplace infections
Shweta Malik, United Kingdom
Thursday 14 November 2024
9h00-10h00 5.P. - Oral presentations: Understanding environmental, social and individual factors Assessing the contribution of smoking to the disease burden in Belgium, 2013-2020
Sarah Nayani, Belgium
11h45-12h45 6.S. - Poster walk: Chronic diseases and NCDs Quantifying Cardiovascular Disease Burden and Quality of Care Index across Four Visegrád Countries
Mohammed Merzah, Hungary
11h45-12h45 6.S. - Poster walk: Chronic diseases and NCDs Family function, psychological distress and burden in informal caregivers of people with dementia
Marta Nemcikova, Slovakia
15h15-16h15 7.E. - Pitch presentations: Health hazards and impact on health Burden and economic impact of PM2.5 exposure on Acute Myocardial Infarction in Portugal, 2011-2021
Francisco Madeira, Portugal
Friday 15 November 2024
9h00-10h00 9.G. - Oral presentations: Risk factors in the development of NCDs Contribution of risk factors to the burden of major illness: a microsimulation in England, 2023-2043
Anna Head, United Kingdom
11h45-12h45 10.L. - Oral presentations: Health policies matter Alcohol policy and alcohol-attributed disease burden in Finland and the Baltic countries 1995-2019
Anastasia Månsson, Sweden

Burden of disease poster displays

DE - Chronic diseases and NCDs DE.28 - Disability-adjusted life years 19 former socialist economies in the European region, 1990 - 2019
Milena Šantrić Milićević, Serbia
DE - Chronic diseases and NCDs DE.39 - Mortality and causes of death in Serbia: redistribution of garbage codes to ischemic heart disease
Željka Stamenković, Serbia
DE - Chronic diseases and NCDs DE.41 - Impact of Noncommunicable Diseases on Years of Life Lost in FB&H During the COVID-19 Pandemic
Šeila Cilović Lagarija, Bosnia and Herzegovina
DE - Chronic diseases and NCDs DE.42 - Impact of Malignant Neoplasms on Years of Life Lost in FB&H During the COVID-19 Pandemic
Sinisa Skočibušić, Bosnia and Herzegovina
DE - Chronic diseases and NCDs DE.43 - Mortality due to ischemic stroke in Serbia after redistribution of the inaccurately coded deaths
Jovana Todorovic, Serbia
DE - Chronic diseases and NCDs DE.52 - The burden of psoriasis in Belgium, 2021
Rani Claerman, Belgium
DE - Chronic diseases and NCDs DE.53 - Burden of inflammatory bowel disease in Belgium, 2020
Rani Claerman, Belgium
DE - Chronic diseases and NCDs DE.84 - Temporal trends, regional and socio-economic disparities of colorectal cancer burden in Cyprus
Andri Assiotou, Cyprus
DF - Climate change / Urban health DF.7 - Urban burden of disease estimation for policy making
Georgia Dyer, Spain
DG - Environment and health / Planetary Health DG.22 - Estimation of Environmental Burden of Disease related to Arsenic exposure in European Populations
Carla Martins, Portugal
DG - Environment and health / Planetary Health DG.46 - The burden of lung cancer attributable to ambient PM2.5 exposure: a systematic literature review
Mariana Corda, Portugal
DG - Environment and health / Planetary Health DG.50 - Health burden and economic costs of vector-borne diseases in Italy: the AUSL Romagna case
Marco Monti, Italy
DG - Environment and health / Planetary Health DG.59 - Cancer mortality attributable to air pollution in Slovakia
Jarmila Pekarcikova, Slovakia
DH - Epidemiology DH.24 - Gender Differences in Years of Life Lost resulting from the 2015 Gorkha Earthquake in Nepal
Margo Tonnelier, Belgium
DK - Health assessments: impact, technology DK.4 - Novel R package to quantify and monetize burden of disease attributable to air pollution and noise
Axel Luyten, Switzerland
DP - Infectious diseases control DP.38 - Uncovering the health system burden of pneumococcal infections in adult and elderly populations
Zach Desson, Belgium
DT - Public health economics DT.2 - Financial burden and coping mechanism for stomach and pancreatic cancer
Mohit Pandey, India
DT - Public health economics DT.3 - Solutions for reducing the severe economic burden of musculoskeletal diseases
Marjetka Jelenc, Slovenia
DT - Public health economics DT.8 - Economic burden of suicide in Sweden in 2022
Inna Feldman, Sweden
DU - Public health monitoring, reporting and foresight DU.18 - The burden of sepsis in Italy: an analysis of treatable mortality trends
Andrea Sanna, Italy
DU - Public health monitoring, reporting and foresight DU.19 - Diabetes mellitus EU comorbidity index: using data from EHIS 2019 and GBD disability weights
Nour Mahrouseh, Hungary
DU - Public health monitoring, reporting and foresight DU.64 - Preventing dementia is possible. The fraction of cases attributable to modifiable factors in Italy
Rosaria Gallo, Italy
DV - Public health policy and politics DV.5 - Reception of health data using the Australian Burden of Disease study as an example
Aline Anton, Germany
DV - Public health policy and politics DV.16 - Exploring Burden of Disease Metrics in EU legislation: A Systematic Analysis
Jose Chen-Xu, Portugal
DW - Public mental health DW.87 - Systematic review of burden&quality of life in caregivers of children with schizophrenia (SyREN)
Marta Caminiti, Italy

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini